21st Century Hearings: Constitution Center October 23-24 #FTC-2018-0090-D-0029

Submission Number:
FTC-2018-0090-D-0029
Commenter:
Tahir Amin
Organization:
Initiative for Medicines, Access & Knowledge
State:
New York
Initiative Name:
21st Century Hearings: Constitution Center October 23-24
For this submission, we focus on a brief examination of the effective market exclusivity for biological medicines and how the patenting practices of originator companies are preventing the early entry of competition.